2017
DOI: 10.4103/njs.njs_57_16
|View full text |Cite
|
Sign up to set email alerts
|

A case of retroperitoneal malignant triton tumor in a Nigerian boy

Abstract: Malignant peripheral nerve sheath tumor is a rare tumor occurring in 5%–10% of all malignant soft tissues sarcomas and triton tumor arising from neurofibromatosis type 1 (NF-1) is even rarer with associated high rate of mortality. No case of triton tumor has been reported in Nigeria to the best of our knowledge. We seek to report a case of lately detected retroperitoneal triton tumor presenting in a 12-year-old Nigerian child who was brought with bilateral lower limb weaknesses, weight loss, and a right lumbar… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
7
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(7 citation statements)
references
References 16 publications
(37 reference statements)
0
7
0
Order By: Relevance
“…However, sites such as the viscera, mediastinum, intracranium, and retroperitoneum are quite rare. Currently, there are less than 10 reported cases of retroperitoneal MTT in relevant literature [3,5]. The rarity of this condition and its clinical signifi cance has prompted the reporting of this case.…”
Section: Introductionmentioning
confidence: 99%
See 3 more Smart Citations
“…However, sites such as the viscera, mediastinum, intracranium, and retroperitoneum are quite rare. Currently, there are less than 10 reported cases of retroperitoneal MTT in relevant literature [3,5]. The rarity of this condition and its clinical signifi cance has prompted the reporting of this case.…”
Section: Introductionmentioning
confidence: 99%
“…While MPNSTs account for only 5%-10% of all soft tissue sarcomas, there exist MPNST variations that occur with greater rarity [2]. Specifi cally, Malignant Triton Tumors (MTT) are a subset of MPNST with rhabdomyoblastic differentiation and account for only 5% of all MPNST cases [3]. MTTs were fi rst described by Mason in 1932 and found to occur in patients with Neurofi bromatosis type 1 (NF-1) in slightly more than 50% of cases.…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…It is a benign tumor of peripheral nerves with proliferating neural crest-derived Schwann cells, perineural cells, and endoneural fibroblasts [1,3,4]. Genetically, it arises from the defective NF1 gene on chromosome 17q11.2 whose protein product neurofibromin is a tumor suppressor and mutates spontaneously in 50% of cases [1,[5][6][7][8][9]. NF1 is inherited as autosomal dominant with complete penetrance and is seen in all races and genders [3,[6][7][8].…”
Section: Introductionmentioning
confidence: 99%